Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Alleviating effect of active hexose correlated compound (AHCC) for anticancer drug-induced side effects in non-tumor-bearing mice.

Shigama K, Nakaya A, Wakame K, Nishioka H, Fujii H.

J Exp Ther Oncol. 2009;8(1):43-51.

PMID:
19827270
2.

The influence of active hexose correlated compound (AHCC) on cisplatin-evoked chemotherapeutic and side effects in tumor-bearing mice.

Hirose A, Sato E, Fujii H, Sun B, Nishioka H, Aruoma OI.

Toxicol Appl Pharmacol. 2007 Jul 15;222(2):152-8. Epub 2007 Apr 20.

PMID:
17555784
3.

Low-dose supplementation with active hexose correlated compound improves the immune response to acute influenza infection in C57BL/6 mice.

Nogusa S, Gerbino J, Ritz BW.

Nutr Res. 2009 Feb;29(2):139-43. doi: 10.1016/j.nutres.2009.01.005.

PMID:
19285605
4.
5.

Combination therapy of active hexose correlated compound plus UFT significantly reduces the metastasis of rat mammary adenocarcinoma.

Matsushita K, Kuramitsu Y, Ohiro Y, Obara M, Kobayashi M, Li YQ, Hosokawa M.

Anticancer Drugs. 1998 Apr;9(4):343-50.

PMID:
9635925
6.

Licochalcone A inhibits the growth of colon carcinoma and attenuates cisplatin-induced toxicity without a loss of chemotherapeutic efficacy in mice.

Lee CK, Son SH, Park KK, Park JH, Lim SS, Kim SH, Chung WY.

Basic Clin Pharmacol Toxicol. 2008 Jul;103(1):48-54. doi: 10.1111/j.1742-7843.2008.00238.x. Epub 2008 Jul 1.

7.

Molecular hydrogen alleviates nephrotoxicity induced by an anti-cancer drug cisplatin without compromising anti-tumor activity in mice.

Nakashima-Kamimura N, Mori T, Ohsawa I, Asoh S, Ohta S.

Cancer Chemother Pharmacol. 2009 Sep;64(4):753-61. doi: 10.1007/s00280-008-0924-2. Epub 2009 Jan 16.

PMID:
19148645
8.
9.

A Phase I study of the safety of the nutritional supplement, active hexose correlated compound, AHCC, in healthy volunteers.

Spierings EL, Fujii H, Sun B, Walshe T.

J Nutr Sci Vitaminol (Tokyo). 2007 Dec;53(6):536-9.

10.

Active hexose correlated compound activates immune function to decrease bacterial load in a murine model of intramuscular infection.

Aviles H, O'Donnell P, Orshal J, Fujii H, Sun B, Sonnenfeld G.

Am J Surg. 2008 Apr;195(4):537-45. doi: 10.1016/j.amjsurg.2007.05.045.

PMID:
18304499
11.

Amelioration by active hexose correlated compound of endocrine disturbances induced by oxidative stress in the rat.

Ye SF, Wakame K, Ichimura K, Matsuzaki S.

Endocr Regul. 2004 Mar;38(1):7-13.

PMID:
15147233
12.

Suppressive effect of active hexose correlated compound (AHCC) on thymic apoptosis induced by dexamethasone in the rat.

Burikhanov RB, Wakame K, Igarashi Y, Wang S, Matsuzaki S.

Endocr Regul. 2000 Dec;34(4):181-8.

PMID:
11137978
13.

The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation.

Tseng CL, Su WY, Yen KC, Yang KC, Lin FH.

Biomaterials. 2009 Jul;30(20):3476-85. doi: 10.1016/j.biomaterials.2009.03.010. Epub 2009 Apr 5.

PMID:
19345990
14.

The effect of active hexose correlated compound in modulating cytosine arabinoside-induced hair loss, and 6-mercaptopurine- and methotrexate-induced liver injury in rodents.

Sun B, Wakame K, Sato E, Nishioka H, Aruoma OI, Fujii H.

Cancer Epidemiol. 2009 Oct;33(3-4):293-9. doi: 10.1016/j.canep.2009.07.006. Epub 2009 Aug 20.

PMID:
19699163
15.

Antitumor effectiveness and toxicity of cisplatin-loaded long-circulating and pH-sensitive liposomes against Ehrlich ascitic tumor.

de Carvalho Maroni L, de Oliveira Silveira AC, Leite EA, Melo MM, de Carvalho Ribeiro AF, Cassali GD, de Souza CM, Souza-Fagundes EM, Caldas IR, Ara├║jo MS, Martins-Filho OA, de Oliveira MC, Teixeira-Carvalho A.

Exp Biol Med (Maywood). 2012 Aug;237(8):973-84. doi: 10.1258/ebm.2012.011432. Epub 2012 Aug 17.

PMID:
22903135
16.

Active hexose correlated compound potentiates the antitumor effects of low-dose 5-fluorouracil through modulation of immune function in hepatoma 22 tumor-bearing mice.

Cao Z, Chen X, Lan L, Zhang Z, Du J, Liao L.

Nutr Res Pract. 2015 Apr;9(2):129-36. doi: 10.4162/nrp.2015.9.2.129. Epub 2014 Dec 26.

17.

Active hexose-correlated compound down-regulates sex-determining region Y-box 2 of pancreatic cancer cells.

Nawata J, Kuramitsu Y, Wang Y, Kitagawa T, Tokuda K, Baron B, Akada J, Suenaga S, Kaino S, Maehara S, Maehara Y, Sakaida I, Nakamura K.

Anticancer Res. 2014 Sep;34(9):4807-11.

PMID:
25202061
18.

Protective effect of an acidic glycoprotein obtained from culture of Chlorella vulgaris against myelosuppression by 5-fluorouracil.

Konishi F, Mitsuyama M, Okuda M, Tanaka K, Hasegawa T, Nomoto K.

Cancer Immunol Immunother. 1996 Jun;42(5):268-74.

PMID:
8706047
19.

Reduction of adverse effects by a mushroom product, active hexose correlated compound (AHCC) in patients with advanced cancer during chemotherapy--the significance of the levels of HHV-6 DNA in saliva as a surrogate biomarker during chemotherapy.

Ito T, Urushima H, Sakaue M, Yukawa S, Honda H, Hirai K, Igura T, Hayashi N, Maeda K, Kitagawa T, Kondo K.

Nutr Cancer. 2014;66(3):377-82. doi: 10.1080/01635581.2014.884232. Epub 2014 Mar 10.

PMID:
24611562
20.

Supplemental Content

Support Center